Skip to main content
Clinical Trials/IRCT20210307050610N1
IRCT20210307050610N1
Recruiting
Phase 3

Investigation the effect of the 24 and 48-hour changing in chloride sodium 0.9% used in infusion of drug on the amount of phlebitis and serum infection

Sabzevar University of Medical Sciences0 sites300 target enrollmentStarted: TBDLast updated:

Overview

Phase
Phase 3
Status
Recruiting
Sponsor
Sabzevar University of Medical Sciences
Enrollment
300

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • People over the age of 18
  • patient consent or caregiver
  • patient cooperation
  • having a drug to be infused
  • patients who have been hospitalized for at least 48 hours

Exclusion Criteria

  • Pregnant patients
  • lactating patients
  • immunocompromised patients
  • Patients with skin and vascular diseases
  • Patients receiving hypertonic serum
  • and patients receiving blood and blood products
  • patients receivingTotal parenteral nutrition
  • Patients with sepsis
  • patients with mental disorders
  • Patients receiving anticoagulants

Investigators

Sponsor
Sabzevar University of Medical Sciences

Similar Trials